FarFaR - Pharmacy Repository
University of Belgrade, Faculty of Pharmacy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Association of Myeloperoxidase and the Atherogenic Index of Plasma in Children with End-Stage Renal Disease

Thumbnail
2017
2954.pdf (70.93Kb)
Authors
Ristovski-Kornić, Danijela
Stefanović, Aleksandra
Kotur-Stevuljević, Jelena
Zeljković, Aleksandra
Spasojević-Kalimanovska, Vesna
Vekić, Jelena
Miljković, Milica
Paripović, Dušan
Peco-Antić, Amira
Jelić-Ivanović, Zorana
Article (Published version)
Metadata
Show full item record
Abstract
Background: The aim of this study was to explore oxidative stress status, especially the enzyme myeloperoxidase in children with end-stage renal disease. Also, we investigated possible associations between the atherogenic index of plasma and these parameters. Methods: Lipid status parameters, oxidative stress status parameters, and myeloperoxidase concentration were measured in the sera of 20 children in the last stage of chronic renal disease (ESRD) and 35 healthy children of matching age and sex. The Atherogenic Index of Plasma (AIP) was calculated according to the appropriate equation. Results: We did not find any significant differences in myeloperoxidase concentrations between the investigated groups (p = 0.394). Oxidative stress parameters were, however, significantly higher in the patient group (p lt 0.001), as well as the atherogenic index of plasma (p lt 0.001). Myelo per oxidase concentration and advanced oxidation protein product (AOPP) concentration were independently a...ssociated with increased AIP in the patient group (p lt 0.05). Conclusions: Changes in AIP in children with ERSD are associated with the oxidative stress status and myeloper oxidase concentration.

Source:
Journal of Medical Biochemistry, 2017, 36, 1, 23-31
Publisher:
  • Društvo medicinskih biohemičara Srbije, Beograd i Versita
Funding / projects:
  • Interactive role of dyslipidemia, oxidative stress and inflammation in atherosclerosis and other diseases: genetic and biochemical markers (RS-175035)

DOI: 10.1515/jomb-2016-0027

ISSN: 1452-8258

PubMed: 28680346

WoS: 000393585400004

Scopus: 2-s2.0-85011304718
[ Google Scholar ]
4
3
URI
https://farfar.pharmacy.bg.ac.rs/handle/123456789/2956
Collections
  • Radovi istraživača / Researchers’ publications
Institution/Community
Pharmacy
TY  - JOUR
AU  - Ristovski-Kornić, Danijela
AU  - Stefanović, Aleksandra
AU  - Kotur-Stevuljević, Jelena
AU  - Zeljković, Aleksandra
AU  - Spasojević-Kalimanovska, Vesna
AU  - Vekić, Jelena
AU  - Miljković, Milica
AU  - Paripović, Dušan
AU  - Peco-Antić, Amira
AU  - Jelić-Ivanović, Zorana
PY  - 2017
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2956
AB  - Background: The aim of this study was to explore oxidative stress status, especially the enzyme myeloperoxidase in children with end-stage renal disease. Also, we investigated possible associations between the atherogenic index of plasma and these parameters. Methods: Lipid status parameters, oxidative stress status parameters, and myeloperoxidase concentration were measured in the sera of 20 children in the last stage of chronic renal disease (ESRD) and 35 healthy children of matching age and sex. The Atherogenic Index of Plasma (AIP) was calculated according to the appropriate equation. Results: We did not find any significant differences in myeloperoxidase concentrations between the investigated groups (p = 0.394). Oxidative stress parameters were, however, significantly higher in the patient group (p  lt  0.001), as well as the atherogenic index of plasma (p  lt  0.001). Myelo per oxidase concentration and advanced oxidation protein product (AOPP) concentration were independently associated with increased AIP in the patient group (p  lt  0.05). Conclusions: Changes in AIP in children with ERSD are associated with the oxidative stress status and myeloper oxidase concentration.
PB  - Društvo medicinskih biohemičara Srbije, Beograd i Versita
T2  - Journal of Medical Biochemistry
T1  - Association of Myeloperoxidase and the Atherogenic Index of Plasma in Children with End-Stage Renal Disease
VL  - 36
IS  - 1
SP  - 23
EP  - 31
DO  - 10.1515/jomb-2016-0027
ER  - 
@article{
author = "Ristovski-Kornić, Danijela and Stefanović, Aleksandra and Kotur-Stevuljević, Jelena and Zeljković, Aleksandra and Spasojević-Kalimanovska, Vesna and Vekić, Jelena and Miljković, Milica and Paripović, Dušan and Peco-Antić, Amira and Jelić-Ivanović, Zorana",
year = "2017",
abstract = "Background: The aim of this study was to explore oxidative stress status, especially the enzyme myeloperoxidase in children with end-stage renal disease. Also, we investigated possible associations between the atherogenic index of plasma and these parameters. Methods: Lipid status parameters, oxidative stress status parameters, and myeloperoxidase concentration were measured in the sera of 20 children in the last stage of chronic renal disease (ESRD) and 35 healthy children of matching age and sex. The Atherogenic Index of Plasma (AIP) was calculated according to the appropriate equation. Results: We did not find any significant differences in myeloperoxidase concentrations between the investigated groups (p = 0.394). Oxidative stress parameters were, however, significantly higher in the patient group (p  lt  0.001), as well as the atherogenic index of plasma (p  lt  0.001). Myelo per oxidase concentration and advanced oxidation protein product (AOPP) concentration were independently associated with increased AIP in the patient group (p  lt  0.05). Conclusions: Changes in AIP in children with ERSD are associated with the oxidative stress status and myeloper oxidase concentration.",
publisher = "Društvo medicinskih biohemičara Srbije, Beograd i Versita",
journal = "Journal of Medical Biochemistry",
title = "Association of Myeloperoxidase and the Atherogenic Index of Plasma in Children with End-Stage Renal Disease",
volume = "36",
number = "1",
pages = "23-31",
doi = "10.1515/jomb-2016-0027"
}
Ristovski-Kornić, D., Stefanović, A., Kotur-Stevuljević, J., Zeljković, A., Spasojević-Kalimanovska, V., Vekić, J., Miljković, M., Paripović, D., Peco-Antić, A.,& Jelić-Ivanović, Z.. (2017). Association of Myeloperoxidase and the Atherogenic Index of Plasma in Children with End-Stage Renal Disease. in Journal of Medical Biochemistry
Društvo medicinskih biohemičara Srbije, Beograd i Versita., 36(1), 23-31.
https://doi.org/10.1515/jomb-2016-0027
Ristovski-Kornić D, Stefanović A, Kotur-Stevuljević J, Zeljković A, Spasojević-Kalimanovska V, Vekić J, Miljković M, Paripović D, Peco-Antić A, Jelić-Ivanović Z. Association of Myeloperoxidase and the Atherogenic Index of Plasma in Children with End-Stage Renal Disease. in Journal of Medical Biochemistry. 2017;36(1):23-31.
doi:10.1515/jomb-2016-0027 .
Ristovski-Kornić, Danijela, Stefanović, Aleksandra, Kotur-Stevuljević, Jelena, Zeljković, Aleksandra, Spasojević-Kalimanovska, Vesna, Vekić, Jelena, Miljković, Milica, Paripović, Dušan, Peco-Antić, Amira, Jelić-Ivanović, Zorana, "Association of Myeloperoxidase and the Atherogenic Index of Plasma in Children with End-Stage Renal Disease" in Journal of Medical Biochemistry, 36, no. 1 (2017):23-31,
https://doi.org/10.1515/jomb-2016-0027 . .

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB